semaglutide and autoimmune disorders Weight loss, disease activity, patient reported outcomes in patients with musculoskeletal and diseases taking weight loss medications: a retrospective cohort study GLP-1 Agonists for Improving Metabolic

For women, hormonal imbalances (particularly during perimenopause and menopause) can affect lipid metabolism, and hormone optimization may provide metabolic benefits

[DOI] [PMC free article] [PubMed] [Google Scholar] 28.GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art

doi: 10.1111/dom.13162

The addressable market for the Cost Plus model is large and commercially significant generic drugs account for 90% of prescription volume even if they represent only 20% of total drug spend but the high-dollar, high-cost corner of the drug market where the most patient harm from pricing occurs remains inaccessible to the model as currently structured

The difference reflects both absorption efficiency and the weekly dosing advantage of injections, which maintain steadier hormone levels throughout treatment